6-K ·Filed Jul 21, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for any material updates (e.g., clinical trial progress, financing) that may emerge from the conference or be disseminated separately. No immediate stock-moving catalyst from this filing alone.
Final — all horizons settled through T+60d ⚠ clustered
ATHE ▼ -42.77% at T+60d
NEUTRAL call -42.77% · α vs SPY -46.74% · entry $4.98 → $2.85
T+1d
-5.62%
call -5.62% · α -5.51%
$4.70
settled 3mo ago
T+5d
-6.33%
call -6.33% · α -5.10%
$4.67
settled 3mo ago
T+20d
-8.38%
call -8.38% · α -10.94%
$4.56
settled 2mo ago
T+60d
-42.77%
call -42.77% · α -46.74%
$2.85
settled 13d ago
Price Chart
Loading chart...
Executive Summary
Alterity Therapeutics filed a 6-K announcing its CEO will participate in the BTIG Biotechnology Conference 2026, hosting 1-on-1 investor meetings virtually on July 28-29. This is a routine investor relations event with no financial or clinical data disclosed.
Key Facts
- CEO David Stamler will participate in the BTIG Biotechnology Conference 2026 (virtual, July 28-29).
- Dr. Stamler will host 1-on-1 meetings with U.S. investors; no presentation or new data announced.
- No material financial, clinical, or regulatory updates were provided in the filing.
Financial Impact
No financial impact from conference participation announcement.
Risk Factors
- Conference participation does not guarantee investor interest or capital raise.
- No new data or guidance was disclosed, limiting near-term catalysts.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-023910 |
| Exhibit: ex_990725.htm | 0001437749-26-023910 |
| Document: 0001437749-26-023910-index-headers.html | 0001437749-26-023910 |
| Document: 0001437749-26-023910-index.html | 0001437749-26-023910 |
| Document: 0001437749-26-023910.txt | 0001437749-26-023910 |
42 reports for ATHE
67% Hit rate @ T+60 Went positive at some point 10 of 10 best @ T+20▲ +27.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (−4.82%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (+4.82%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (+4.82%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.19 (−8.34%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.19 (−8.34%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.19 (−9.85%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.19 (−29.79%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.19 (−31.97%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.19 (−31.97%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.19 (−40.31%) |
Showing 10 of 42
US Market Status
Market Open — Closes in 3h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers